COVID19: Dexamethasone;death or deliverer therefrom?

摘要: Background: A multitude and wide array of various drugs have been postulated some even attempted to be used as effective treatments against the virus The ranged from antimalarials in India a prophylaxis disease;namely chloroquine hydroxychloroquine, use broad-spectrum antiviral such Remdesivir Dexamethasone, cheap, widely available, long acting corticosteroid has gaining popularity extent fame treatment COVID19 patients The benefits thereof were made apparent after very successful research conducted by University Oxford Recovery trial, which is one world’s largest clinical trials This trial reported on June 16, 2020 that Dexamethasone at dosage 6 mg per day for 10 days dramatically reduced mortality particularly COVID ventilators dexamethasone proved beneficial milder cases disease well death 20% those proposed mechanism action drug acts via impeding dangerous cytokine storm, an intense immune response severely renders lungs damaged storm attributed severe complications respiratory failure noted would suppress this autoimmune destruction inflammatory reaction, thereby sparing patient’s life Conclusion: It therefore paramount importance further studied understood are undeniable should implemented into regime with guarded approach